# Health Economic Analysis of Islet Cell Transplantation for the Stabilization of the Severe Forms of Type 1 Diabetes

> **NCT02854696** · PHASE3 · UNKNOWN · sponsor: **University Hospital, Grenoble** · enrollment: 42 (actual)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **PROCEDURE:** Islet graft
- **DRUG:** best medical care

## Key facts

- **NCT ID:** NCT02854696
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-07-07
- **Primary completion:** 2023-05
- **Final completion:** 2023-12
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2022-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02854696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02854696, "Health Economic Analysis of Islet Cell Transplantation for the Stabilization of the Severe Forms of Type 1 Diabetes". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02854696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*